Salvadori Daniel Gesua Sive
SEC CIK 1620564 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ABT | Abbott Laboratories | EVP AND GROUP Pres | 146.4K | — | $19.65M | 21 | 2021-12-13 | 2026-03-02 |
Most active insiders at ABT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ford Robert B | COB AND CEO, Dir | $2.01M | $46.20M |
| 2 | STARKS DANIEL J | Dir | $2.01M | — |
| 3 | Morrone Louis H. | EVP | — | $774.7K |
| 4 | Shroff Eric | SVP | — | $285.0K |
| 5 | Boudreau Philip P | EVP AND CFO | $201.3K | — |
| 6 | Stratton John G | Dir | $173.6K | — |
| 7 | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | — | $102.3K |
| 8 | Moreland Mary K | EVP | — | $70.9K |
| 9 | MCCOY JOHN A. JR. | VP AND Ctrl | — | $70.6K |
| 10 | Cushman Elizabeth C. | EVP, GC AND Sec | — | $30.4K |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-03 | 2026-02-27 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | F - Tax | $116.26 | -6,615 | 147.3K | -4% | -$769.1K | |
| 2026-03-03 | 2026-03-02 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | S - Sale | $115.58 | -885 | 146.4K | -0.6% | -$102.3K | |
| D | 2026-02-26 | 2026-02-24 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | A - Grant | $0.00 | +21.6K | 153.9K | +16% | $0 |
| 2025-12-12 | 2025-12-11 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | G - Gift | $123.28 | -1,536 | 132.2K | -1% | -$189.4K | |
| 2025-03-04 | 2025-02-28 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP AND GROUP Pres | F - Tax | $135.87 | -8,462 | 133.8K | -6% | -$1.15M | |
| D | 2025-02-27 | 2025-02-25 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | A - Grant | $0.00 | +16.5K | 142.2K | +13% | $0 |
| D | 2025-01-31 | 2025-01-30 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | S - Sale+OE | $128.50 | -23.8K | 125.7K | -16% | -$3.05M |
| D | 2025-01-31 | 2025-01-30 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | M - OptEx | $38.40 | +23.8K | 149.5K | +19% | +$912.8K |
| 2024-03-04 | 2024-03-01 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | S - Sale | $118.50 | -963 | 125.7K | -0.8% | -$114.1K | |
| 2024-03-04 | 2024-02-29 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | F - Tax | $120.05 | -8,874 | 126.7K | -7% | -$1.07M | |
| D | 2024-02-23 | 2024-02-21 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | A - Grant | $0.00 | +15.7K | 135.5K | +13% | $0 |
| 2023-03-02 | 2023-02-28 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | F - Tax | $99.77 | -9,002 | 120.9K | -7% | -$898.1K | |
| 2023-03-02 | 2023-03-01 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | S - Sale | $100.70 | -1,085 | 119.9K | -0.9% | -$109.3K | |
| D | 2023-02-22 | 2023-02-17 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | A - Grant | $0.00 | +17.7K | 129.9K | +16% | $0 |
| 2022-03-02 | 2022-02-28 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | F - Tax | $122.41 | -10.6K | 113.8K | -8% | -$1.29M | |
| 2022-03-02 | 2022-03-01 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | S - Sale | $118.17 | -1,550 | 112.2K | -1% | -$183.2K | |
| D | 2022-02-23 | 2022-02-18 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | A - Grant | $0.00 | +23.9K | 124.3K | +24% | $0 |
| DM | 2021-12-28 | 2021-12-23 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | M - OptEx | $41.81 | +55.0K | 158.9K | +53% | +$2.30M |
| D | 2021-12-28 | 2021-12-23 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | S - Sale+OE | $140.00 | -58.5K | 100.4K | -37% | -$8.19M |
| DM | 2021-12-15 | 2021-12-13 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | M - OptEx | $41.81 | +55.0K | 158.9K | +53% | +$2.30M |
| DM | 2021-12-15 | 2021-12-13 | ABT | Abbott Laboratories | Salvadori Daniel Gesua Sive | EVP | S - Sale+OE | $135.00 | -58.5K | 103.9K | -36% | -$7.90M |
Purchase Sale Sale after option exercise All abbreviations